"Strong Teeth": an early-phase study to assess the feasibility of an oral health intervention delivered by dental teams to parents of young children.

BACKGROUND: Tooth decay (caries) is a significant health burden in young children. There is strong evidence for the benefits of establishing appropriate home-based oral health behaviours in early childhood. Dental teams are well placed to provide this information and there is clear advice on what oral health information should be given to parents. However, research has shown that there is limited guidance, training and resources on how dental teams should deliver this advice. "Strong Teeth" is a complex oral health intervention, using evidence-based resources and training underpinned by behaviour change psychology, to support behaviour change conversations in dental practice. This early phase evaluation aims to assess the feasibility of this intervention, prior to a full-scale trial. METHODS: The study recruited 15 parents of children aged 0-2-years-old and 21 parents of children aged 3-5 years old, from five NHS dental practices across West Yorkshire. Participant demographics, self-reported brushing behaviours, dietary habits, a dental examination and three objective measures of toothbrushing were collected in a home-setting at baseline, then at 2-weeks and 2-months post-intervention. Recruitment, retention and intervention delivery were analysed as key process outcomes. Brushing habits were compared to national toothbrushing guidelines - the Delivering Better Oral Health toolkit (Public Health England). RESULTS: Strong Teeth was feasible to deliver in a General Dental Practice setting in 94% of cases. Feasibility of recruitment (37%) exceeded progression criterion, however retention of participants (75%) was below the progression criterion for the 0-2 age group. More than half of children recruited aged 3-5-years had caries experience (52%). Total compliance to toothbrushing guidance at baseline was low (28%) and increased after the intervention (52%), an improvement that was statistically significant. Dietary habits remained largely unchanged. Plaque scores significantly decreased in the 3-5-year-olds and toothbrushing duration increased in all age groups. CONCLUSION: "Strong Teeth" intervention delivery and data collection in the home setting was feasible. There was a positive indication of impact on reported toothbrushing behaviours. Some amendments to study design, particularly relating to the inclusion of the 0-2-year-old group, should be considered before progression to a full trial. Trial registration ISRCTN Register: ISRCTN10709150. Registered retrospectively 24/7/2019.

[Outcome of intensive medical care for inflammatory rheumatic diseases]. / Outcome intensivmedizinischer Betreuung bei rheumatischen Erkrankungen.

BACKGROUND AND OBJECTIVE: Very little is known about the outcome of patients with inflammatory rheumatic diseases in intensive care units (ICU). This retrospective study investigated the results of intensive medical treatment in these patients and the reliability of scoring systems used for the prediction of survival. MATERIAL AND METHODS: A case group consisting of 50 patients suffering from inflammatory rheumatic diseases was generated by analysis of patient records from the ICU at the University Hospital for Internal Medicine in Halle (Saale) in the years 2001-2010. The APACHE II score and SAPS II were used to estimate the probable mortality rate. The data were compared to those of a control group consisting of 72 patients treated on the ICU and suffering from non-inflammatory joint diseases. RESULTS: In the case group a higher mortality rate (38 % vs. 20.8 %) and a higher frequency of respiratory, nephrogenic and cardiovascular complications were observed. In addition, these patients more often underwent artificial ventilation (66 % vs. 35 %) and had a higher rate of infections (74 % vs. 40.3 %) compared to the control group. In patients with inflammatory rheumatic diseases the SAPS II was not useful for correctly predicting mortality, whereas the APACHE II score showed sufficient agreement with the actual mortality rate. CONCLUSION: Patients with inflammatory rheumatic diseases displayed a poorer outcome compared with the control group in the course of the intensive care treatment. Universally applied scoring systems used to predict mortality are of limited value in this patient population.

Cutting the cost of South African antiretroviral therapy using newer, safer drugs.

Antiretrovirals are a significant cost driver for HIV programmes. Current first-line regimens have performed well in real-life programmes, but have a low barrier to virological resistance and still carry toxicity that limits adherence. New drug developments may mean that we have access to safer, more robust and cheaper regimens, but only if the appropriate clinical trials are conducted. We briefly discuss these trials, and demonstrate the large cost savings to the South African HIV programme if these are successful.

Relationship between serum insulin-like growth factor-I and genotype during the postpartum interval in beef cows.

The objective of this study was to determine the effect of genotype and week postpartum on serum concentrations of IGF-I, body condition score (BCS), BW, and ovarian function in beef cows. Cows from the following genotypes were utilized in two consecutive years: Angus (A x A; n = 9), Brahman (B x B; n = 10), Charolais (C x C; n = 12), Angus x Brahman (A x B; n = 22), Brahman x Charolais (B x C; n = 19) and Angus x Charolais (A x C; n = 24). Serum concentrations of IGF-I, BCS, and BW were determined between wk 2 and 9 postpartum. Rectal ultrasound was used to determine days postpartum to first medium (6 to 9 mm) and first large (> or = 10 mm) follicle. Averaged across genotype, BCS decreased (P < 0.05) from 5.0 +/- 0.1 on wk 3 to 4.8 +/- 0.1 on wk 6 postpartum, and BW decreased (P < 0.05) between wk 2 and 3 and again between wk 4 and 9 postpartum. Averaged over year and week postpartum, serum IGF-I concentrations were greatest (P < 0.05) in B x B cows (46 +/- 5 ng/mL) compared with all other genotypes; lowest in A x A (12 +/- 4 ng/mL), C x C (13 +/- 4 ng/mL), and A x C cows (18 +/- 3 ng/mL); and intermediate (P < 0.05) in A x B (28 +/- 3 ng/mL) and B x C (26 +/- 3 ng/mL) cows compared with all other genotypes. Serum IGF-I concentrations did not change (P > 0.10) with week postpartum in C x C, A x A, and A x C cows, but increased (P < 0.05) between wk 2 and 7 postpartum in B x C, A x B, and B x B cows. Average interval to first medium (16 +/- 2 d) and first large (35 +/- 2 d) follicle did not differ (P > 0.10) among genotypes. Serum IGF-I concentrations correlated with BCS (r = 0.53 to 0.72, P < 0.001) but not with days to first large follicle (r = -0.19 to -0.22, P > 0.10). Averaged across genotypes, cows that lost BCS postpartum had lower (P < 0.01) serum IGF-I concentrations. Cows that calved with adequate BCS (i.e., > or = 5) had greater (P < 0.01) serum IGF-I concentrations postpartum than cows that calved with inadequate BCS (i.e., < 5) but days to first large and medium follicle did not differ (P > 0.10). In conclusion, concentrations of IGF-I in serum differed among genotypes and were associated with BCS but not days to first large or medium follicle in postpartum beef cows.

Norgestomet implants prevent pregnancy in beef heifers on pasture.

The efficacy of erodible norgestomet implants for preventing pregnancy in postpubertal heifers was evaluated in two experiments at five locations each. Heifers (n = 896) within each study location were stratified by weight and allotted randomly to receive an ear implant containing either 0, 24, 36, or 48 mg of norgestomet (d 0). Heifers were exposed to fertile bulls immediately after implantation for 75 d (d 0 to 74) in Exp. 1 (n = 476) or for 80 d (d 75 to 154) in Exp. 2 (n = 420). Weights were recorded on d 0 and 74 (Exp. 1 and 2) and d 154 (Exp. 2). Each heifer was palpated rectally for pregnancy at the end of each experiment. Pregnancy rates were higher (P < .01) for control heifers (0 mg implant) than for heifers that received 24, 36, or 48 mg of norgestomet. In Exp. 1, pregnancy rates were 96, 29, 6, and 4% for heifers that received 0, 24, 36, and 48 mg implants of norgestomet, respectively. In Exp. 2, pregnancy rates were 85, 36, 19, and 9% for heifers that received 0, 24, 36, and 48 mg implants of norgestomet, respectively. Estrous activity during the first 3 wk of bull exposure was reduced (P < .05) among heifers that received norgestomet implants compared to control heifers but was not completely abolished at any dosage in Exp. 1. During the first 75 d of Exp. 1 and 2, heifers treated with 36 or 48 mg norgestomet implants gained weight faster (P < .05) than control heifers. Combined across both experiments, ADG during the first 74 d were .53, .56, .59, and .60 kg/d for heifers treated with 0, 24, 36, and 48 mg implants of norgestomet, respectively. These data indicate that norgestomet implants increased rate of weight gain, reduced estrous activity, and reduced the occurrence of pregnancy in heifers on pasture.

The efficacy of predicting dystocia in yearling beef heifers: I. Using ratios of pelvic area to birth weight or pelvic area to heifer weight.

Three methods for predicting difficult births were tested on 4,140 yearling heifers measured before breeding and(or) at pregnancy check approximately 6 mo later. These heifers were from 115 beef herds in Alberta and British Columbia. The overall incidence of dystocia for normal presentations was 26.5%, which included 17.2% easy assists, 7.7% hard pulls, and 1.6% Caesarean sections. In Method 1, heifers were predicted as difficult (hard pull and Caesarean section) or easy (unassisted and easy pull) calvers by dividing their pelvic area (PA) by previously calculated PA to calf birth weight (PA/BWT) ratios. The ratio used depended on heifer weight and age. Method 1 predicted 63.7% to be difficult calvers. Of these only 10.4% were actually difficult calvers. The accuracy of this method was 40.0% and was not a useful on-farm method for predicting difficult births in first-calf, 2-yr-old heifers. In Method 2, 3,278 heifers measured before breeding and 1,125 heifers measured at pregnancy check were predicted as difficult or easy calvers by dividing their PA by 4.19 at prebreeding or 5.51 at pregnancy check. These values were PA/calf BWT ratios previously determined to be threshold levels. The accuracy of Method 2 was 78.5% and culling by this method would have reduced difficult birth rate by 9.6%. However, of the 738 heifers (16.8%) predicted to be difficult calvers, 86.0% actually calved easily. Heifers predicted to be easy calvers by Method 2 were heavier (P < .001), had a larger PA (P < .001), had more PA per kilogram of BW (P < .001), and had heavier (1.0 kg) calves at birth (P = .05) than heifers predicted to be difficult calvers. In Method 3, 3,269 heifers measured before breeding and 1,087 heifers measured at pregnancy check were predicted as difficult or easy calvers by dividing their PA by their BW. Heifers having ratios that were among the lowest 16% of the herd were predicted to be difficult calvers, and the rest were predicted to be easy calvers. The accuracy of Method 3 was 79.4% and culling by this method would have reduced difficult birth rate by 9.5%. However, of the 677 (15.5%) heifers predicted to be difficult calvers, 85.7% actually calved easily. Heifers predicted to be easy calvers by Method 3 were lighter (P < .001), had a larger PA (P < .001), had more PA per kilogram of BW (P < .001), and had lighter (1.2 kg) calves at birth (P = .04) than heifers predicted to be difficult calvers.(ABSTRACT TRUNCATED AT 400 WORDS)

The efficacy of predicting dystocia in yearling beef heifers: II. Using discriminant analysis.

Discriminant analysis was used to develop equations for predicting dystocia in 2-yr-old, first-calf beef heifers. Data collected on 893 yearling heifers from 34 farms were used to derive four sets of prediction equations (Data Set 1). There was a set of equations for British x British (BRBR) heifers at prebreeding, BRBR heifers at pregnancy check, Continental x British-Continental x Continental (CNBR-CNCN) heifers at prebreeding, and CNBR-CNCN heifers at pregnancy check. A second set of data collected on 3,728 heifers at prebreeding and 875 heifers at pregnancy check were used to test these equations (Data Set 2). Measurements taken prebreeding and at pregnancy check included heifer age, weight, body condition score, pelvic height, pelvic width, pelvic area, hip height, and shoulder height. A precalving estimate of average calf birth weight (AVGBWT) and actual calf birth weight (BWT) were also recorded. When actual calf BWT was used, the prediction equations developed for BRBR heifers at prebreeding and at pregnancy check correctly classified 84.6 and 88.5% of the heifers in Data Set 1, respectively. The prediction equations developed for CNBR-CNCN heifers correctly classified 88.1% of the heifers at prebreeding and 87.9% at pregnancy check. When AVGBWT was used, the accuracy of these four sets of prediction equations ranged from 77.1 to 83.1% for heifers in Data Set 1. In Data Set 2, the prebreeding equations correctly classified 78.5% of BRBR and 79.0% of CNBR-CNCN heifers when AVGBWT was used. Culling by these prebreeding equations would have reduced difficult birth rate in BRBR and CNBR- CNCN heifers by 8.5 and 15.7%, respectively.(ABSTRACT TRUNCATED AT 250 WORDS)

Effect of lasalocid on the GnRH-induced LH and testosterone release during puberal development in the Brahman bull.

To determine the effect of lasalocid on endocrine patterns associated with puberty, 12 half-sib prepuberal Brahman bulls were allotted by age and weight (174 to 256 d of age; 141 to 243 kg) to control or lasalocid treatments. Bulls in the control treatment were fed a 4:1 corn:cottonseed meal concentrate plus Coastal bermudagrass hay to which the bulls were given ad libitum access. The lasalocid treatment was identical except for the addition of 200 mg of lasalocid.animal-1.d-1. Blood samples were collected frequently before and after GnRH (200 micrograms, i.m.) on d 7, at 28-d intervals thereafter, and within 14 d after puberty (defined as 50 x 10(6) sperm cells with 10% motility). By d 7, bulls fed lasalocid released more LH (P less than .05), but not testosterone (T;P greater than .10), in response to GnRH than controls. At the time that the first sperm cells were observed in an electroejaculate (FS), lasalocid-fed bulls released more (P less than .05) LH and T than controls. At puberty, there was no difference (P greater than .10) between treatments in amount of T released, although lasalocid-fed bulls released more LH (P less than .05). Before puberty, concentrations of LH were positively correlated with concentrations of T in samples collected 1 and 2 h later. Both groups of bulls exhibited a linear increase in T response with advancing age (P less than .005). Release of LH decreased with age in the control bulls (P less than .10) but was unaffected by age in lasalocid-fed bulls. Both groups showed a decreased (P less than .001) LH:T response ratio with advancing age. Results of this study with bulls confirm previous reports in heifers of the enhancing effect of an ionophore on reproductive function.

Insulin-like growth factor I in follicular development and function in postpartum beef cows.

The objective of this study was to determine whether nutrition affects follicular growth and(or) steroid and insulin-like growth factor I (IGF-I) concentrations in follicular fluid. Beginning 6 d after calving, Hereford-cross cows (n = 28) were fed either 14 (ad libitum) or 7 (restricted) kg.animal1.d-1 of chopped alfalfa-brome hay. Half the cows in each treatment were ovariectomized on d 20 (OVX-20) and the remaining half on d 35 (OVX-35) postpartum. Cow weight and condition score were recorded weekly, and blood was collected thrice weekly for determination of insulin, IGF-I, glucose, and free fatty acid (FFA) concentrations. At ovariectomy, follicular fluid from each follicle greater than or equal to 4 mm in diameter was aspirated for determination of IGF-I, progesterone (P4), and estradiol-17 beta (E2) concentrations. Restricted cows lost more weight after calving than did ad libitum cows (P less than .0001), although all cows lost similar amounts of body condition (time postpartum, P = .008). Concentrations of FFA were elevated (P less than .0001) in restricted cows from wk 2 through 5 after calving but did not change with time in ad libitum cows. Plasma concentrations of glucose were lower in restricted than in ad libitum cows (59.6 +/- .4 vs 61.8 +/- .4 mg/dl; P = .05), but insulin and IGF-I were similar (P greater than .10) between dietary treatments.(ABSTRACT TRUNCATED AT 250 WORDS)

Serum concentrations of IGF-I in postpartum beef cows.

Four experiments assessed changes in serum IGF-I under various physiologic conditions in postpartum cows. In Exp. 1, anestrous suckled cows (n = 25) were infused for 6 d with either saline or glucose at two different infusion rates. In Exp. 2, anestrous cows (n = 29) received either a saline (weaned and suckled controls) or 3 g/d phlorizin (weaned phlorizin) infusion for 3 d. Calves from the weaned groups were removed from 15 h before and throughout infusions. In Exp. 3, cycling suckled cows (n = 20) received prostaglandin F2 alpha (PGF2 alpha) when the 5-d saline or phlorizin infusion began. In Exp. 4, suckled cows (n = 20) had ad libitum access to feed or received 50% of control feed consumption from 30 to 40 d postpartum. Increasing glucose availability (Exp. 1) increased (P less than .05) serum IGF-I by 30 to 35%. IGF-I remained stable after weaning (Exp. 2) in phlorizin-infused cows (128.8 +/- 12.7 ng/ml), but increased (P less than .05) by 3 d after calf removal in weaned control cows (152.2 +/- 7.5 ng/ml). IGF-I also remained stable in phlorizin-infused cows following PGF2 alpha injection (Exp. 3), but increased in control cows by 2 d after PGF2 alpha (156.8 +/- 18.3 on d 2 vs. 133.7 +/- 9.8 ng/ml pre-injection; P less than .05) and remained elevated (P less than .05) during the periovulatory period. In cows receiving restricted feed intake (Exp. 4), IGF-I decreased by approximately 50% within 4 d of feed restriction (71.3 +/- 9.4 vs 137.4 +/- 16.6 ng/ml; P less than .05).(ABSTRACT TRUNCATED AT 250 WORDS)

Follicular phase gonadotropin secretion in cyclic postpartum beef cows with phlorizin-induced hypoglycemia.

Twenty mature, lactating Hereford-cross cows were used to determine the effect of phlorizin-induced hypoglycemia on gonadotropin secretion following prostaglandin-induced luteolysis. Cows were 43 to 108 d postpartum and had a functional corpus luteum (CL) at the start of infusion treatment (d 1). Infusions consisted of either saline (control) or 3 g/d of phlorizin infused continuously from the time of prostaglandin injection at 1000 on d 1 until 0800 on d 5. Blood samples were collected for determination of plasma concentrations of insulin, glucose and free fatty acids (FFA) and for serum concentrations of luteinizing hormone (LH), follicle-stimulating hormone (FSH) and progesterone. Plasma concentrations of insulin (P less than .05) and glucose (P less than .05) were lower, whereas FFA concentrations increased (day X treatment, P less than .05) over the infusion period in phlorizin-treated cows compared with saline-infused controls. Mean serum concentrations of LH (1.17 +/- .10 vs 1.53 +/- .20 ng/ml; P less than .05) and LH pulse amplitude (1.69 +/- .14 vs 2.47 +/- .37 ng/ml; P less than .10) were lower in phlorizin-infused compared with saline-infused cows during the 0 to 24-h period immediately preceding the ovulatory gonadotropin surge. The FSH pulse frequency increased (.33 +/- .11 to .55 +/- .12 pulses/h) in saline-infused cows, but decreased (.61 +/- .10 to .41 +/- .11 pulses/h) in phlorizin-infused cows before the gonadotropin surge. Other characteristics of gonadotropin secretion were similar among phlorizin-infused and saline-infused cows. All but one phlorizin-infused cow ovulated and formed functional CL similar to controls.(ABSTRACT TRUNCATED AT 250 WORDS)

Corpus luteum function following spontaneous or prostaglandin-induced estrus in Brahman cows and heifers.

Corpus luteum (CL) function following spontaneous or prostaglandin F2 alpha-induced estrus was studied in 27 Brahman cows and 16 Brahman heifers. Females received one injection of 0, .38, .75 or 2.25 mg alfaprostol (PGF)/100 kg body weight at 12 +/- .1 d post-estrus. Serum progesterone (P4) during CL formation, following the subsequent estrus, increased over time (P less than .001, 1 to 13 d post-estrus) and was influenced by PGF (P less than .06) and a PGF X time interaction (P less than .02). Low serum P4 concentrations were observed during CL formation (d 3, 4, 10, and 12) in cattle that received 2.25 mg PGF. On d 13 post-estrus, CL were removed. No differences in weight, P4 content or number of luteinizing hormone (LH) receptors was evident between CL derived 13 d following spontaneous vs PGF-induced estrus. The CL formed following PGF-induced estrus had fewer large (P less than .002) and small (P less than .09) luteal cells in heifers, a lower (P less than .008) percentage composition of histological type I and II luteal cells in cows and a lower (P less than .0001) in vitro P4 response to LH in both cows and heifers when compared with the CL formed following spontaneous estrus. Cows had heavier (P less than .002) CL with a higher (P less than .05) number of large cells, a higher (P less than .09) percentage composition of histological cell type I and II luteal cells, and a higher (P less than .03) in vitro basal and stimulated P4 secretion. It is concluded that 1) the events associated with artificially shortening the estrous cycle with PGF altered subsequent CL function in Brahman females; 2) cows had heavier CL, which were composed of more steroidogenically functional luteal cells, than heifers and 3) age of animal interacted with PGF to alter subsequent CL function in Brahman females.

Effects of progesterone and weaning on LH and FSH responses to naloxone in postpartum beef cows.

Two experiments were conducted to evaluate the effects of naloxone, an endogenous opioid receptor antagonist, on LH and FSH secretion in postpartum beef cows. In Experiment 1, 24 cows were divided into three equal groups. On day 15 postpartum, all cows were bled for 8 hr at 10 min intervals to evaluate LH secretory parameters. On day 18 postpartum, three treatments were administered: (a) saline at 0730 and 1130 hr; (b) 275 mg naloxone at 0730 and 1130 hr; (c) naloxone as in (b) above, plus this group was also treated with 50 mg progesterone (P4) twice daily from day 16 to day 19. In each treatment, jugular vein samples were collected at 10 min intervals from 0800 to 1600 hr. On day 19 the same treatments were administered at the same times, however, all cows were given 25 micrograms GnRH at 1200 hr to evaluate the LH secretory response. Naloxone increased mean LH concentration (P less than .05) and tended to increase pulse amplitude and frequency compared to controls. However, the most dramatic difference was due to P4 treatment which suppressed mean LH, pulse amplitude and frequency. Treatments had no effect on LH secretion in response to a 25 micrograms dose of GnRH. In Experiment 2, the effects of suckling on the naloxone response were examined in 16 postpartum cows. On day 21 postpartum, blood was collected at 10 min intervals for 8 hr and then calves were removed from half the cows. After 3 days of calf removal, all cows were sampled at 10 min intervals for 4 hr; then naloxone was injected after each 10 min sample at a dose rate of 200 mg/hr (33 mg per injection). Naloxone treatment and sampling continued for an additional 8 hr. Calf removal alone had very little effect on LH pulsatility. However, naloxone resulted in increased pulse frequency and mean LH compared to the control period. We conclude that LH release in the early postpartum cow is partially regulated by endogenous opioid peptides. We were unable to detect any effects on FSH secretion nor on pituitary sensitivity to exogenous GnRH.

Hypoglycemia alters pulsatile luteinizing hormone secretion in the postpartum beef cow.

This study tested the hypothesis that the increased glucose requirement of lactation had effects that were independent of the suckling-dependent inhibition of postpartum endocrine function in beef cows. Mature Hereford cows were either suckled ad libitum and infused with saline iv (n = 9) from d 2 through 4 (d 0 = jugular catherization on d 32 +/- 3 postpartum); were nonsuckled and infused with saline from d 2 through 4 (n = 10); or were nonsuckled and infused with phlorizin (3 g/d) from d 2 through 4 (n = 10). Nonsuckled cows infused with phlorizin had lower (P less than .05) plasma concentrations of glucose and amino acid nitrogen (AAN) on d 2 compared with pre-infusion levels (d 1), but their metabolic profile returned to levels similar to the suckled cows by d 3 and 4. Nonsuckled cows infused with saline had elevated glucose and insulin and lower AAN and free fatty acids (FFA) on d 3 and 4 compared with pre-weaning (d 1) levels (P less than .05). Nonsuckled cows infused with phlorizin did not show this weaning-induced elevation in glucose and insulin. The number of luteinizing hormone (LH) pulses was not affected by treatment. However, in contrast to the large LH pulses observed in the nonsuckled cows infused with saline, both the suckled cows and the nonsuckled cows treated with phlorizin had more small and fewer large amplitude pulses (P less than .01). Treatment did not affect serum concentrations of follicle stimulating hormone, gonadotropin release in response to gonadotropin releasing hormone (25 micrograms) or the number of cows ovulating by 55 d after calving. We conclude that the increased glucose clearance caused by phlorizin infusion or lactation results in depression of LH pulse amplitude in suckled postpartum beef cows.

Failure of human chorionic gonadotropin injections to sustain gonadotropin-releasing hormone-induced corpora lutea in postpartum beef cows.

Anestrous postpartum (PP) Hereford cows (n =20) were used to determine the effects of repeated injections of human chorionic gonadotropin (hCG) on the progesterone (P4) secretion and functional lifespan of gonadotropin-releasing hormone (GnRH)-induced corpora lutea (CL). Suckling was reduced to once a day from Day 21 to Day 25 PP, and all cows received injections of 200 micrograms GnRH at 1500 h on Day 24 PP to induce ovulation. Treated cows (HCG, n = 10) received 200 IU hCG b.i.d. from 1900 h on Day 27 PP to 1900 h on Day 33 PP; control cows (CTRL, n=10) were not injected. Blood was collected on Days 21, 23, 25, and 27 to 33, 35, 37, and 39 PP. Serum P4 concentration was measured by radioimmunoassay and used to classify luteal lifespan and the associated estrous cycle as short (SHORT) or normal (NORM) in duration. Treatment with hCG resulted in more (p less than 0.01) cows with SHORT cycles (7 of 9 vs. 4 of 9). Serum P4 concentrations were similar (p greater than 0.20) between groups from 4 days before until 6 days after GnRH injection. Cows with NORM cycles (n = 7) had greater serum P4 concentrations (p less than 0.05) on Days 7 to 11 after GnRH than cows with SHORT cycles (n = 11). By Day 39 PP, all cows with SHORT cycles appeared to have undergone a second ovulation. Charcoal-stripped serum pools from before (PRE) and during hCG injection (INJ) were assayed for total luteinizing hormone-like bioactivity (LH-BA) using a dispersed mouse-Leydig cell bioassay.(ABSTRACT TRUNCATED AT 250 WORDS)

Nonpuberal estrus in beef heifers.

The frequency of occurrence of behavioral estrus without subsequent development of functional luteal tissue (termed nonpuberal estrus, NPE), was determined in 43 Simmental X Hereford-Brahman heifers. Blood samples were collected weekly from the start of the study to first behavioral estrus and then daily from d 1 (d 0 = estrus) through d 14 following first and subsequently observed estrous behaviors. All blood samples were analyzed for serum progesterone (P4) concentrations by radioimmunoassay. More heifers (62.8%) exhibited NPE than had luteal development after their first behavioral estrus (37.2%). There was a tendency for fewer light-weight heifers (less than or equal to 240 kg at the start of the experiment) to exhibit a puberal first estrus compared with the heavy-weight (greater than 240 kg at the start of the experiment) heifers (31.2% vs 68.8%, respectively; P = .12). Heifers that had a puberal first estrus were older (376 +/- 12 d vs 334 +/- 9 d, P less than .05) compared with heifers that had NPE. Weight at first behavioral estrus was similar between heifers that had a puberal first estrus and those that had NPE (298 +/- 8 kg and 289 +/- 6 kg, respectively). More heifers that had a puberal first estrus also had an elevation in serum P4 concentrations before that first estrus (64.3% vs 20.0%, P less than .05), and the serum P4 elevation was greater (2.5 +/- .4 ng vs 1.2 +/- .1 ng, P less than .05) than heifers that had NPE. We have concluded from these results that NPE is a common occurrence in heifers approaching puberty.(ABSTRACT TRUNCATED AT 250 WORDS)

Changes in metabolic and reproductive characteristics associated with lactation and glucose infusion in the postpartum ewe.

This study examined mechanisms whereby the metabolic environment interacts with basic reproductive function. Ewes lambing during the breeding season were fed to maintain (MAINT, n = 10) or gain (GAIN, n = 11) body weight during the last 4 mo of gestation. From d 7 to 22 postpartum, ewes were infused iv with saline (n = 10) or glucose at a rate calculated to increase normal glucose entry rate by 75% (n = 11). Blood samples were collected daily to determine plasma concentrations of nutritive metabolites and insulin and at frequent intervals on d 14 and 21 to determine serum gonadotropin concentrations. Hypothalami and pituitaries were collected on d 22 to determine hormone content and receptor concentrations. Plasma concentrations of nutritive metabolites and insulin indicated that MAINT ewes mobilized more (P less than .01) body fat and protein reserves during gestation and early lactation than ewes in the GAIN group. Glucose infusion elevated plasma concentrations of glucose (P less than .05) and insulin (P less than .07) and reduced (P less than .05) fat and protein mobilization, even though it depressed feed intake (P less than .001), compared with saline infusion. Hypothalamic gonadotropin-releasing hormone (GnRH), pituitary luteinizing hormone (LH) and follicle-stimulating hormone (FSH) content and pituitary GnRH receptor concentration were similar between treatments.(ABSTRACT TRUNCATED AT 250 WORDS)

Effect of lasalocid on growth and puberal development in Brahman bulls.

Twenty-four half-sib Brahman bulls (171 to 276 d of age; 140.9 to 243.2 kg) were paired by age and weight and randomly allotted to one of two treatment groups (12 bulls/treatment) with two replicates (six bulls/replicate). Control treatment (C) was a 4:1 corn (IFN 4-02-931):cotton-seed meal (IFN 3-01-621) diet fed at 1% of the average body weight plus Coastal bermudagrass hay (IFN 1-00-716) ad libitum. Lasalocid treatment (L) was the control diet with the addition of 200 mg lasalocid X head-1 X d-1. Lasalocid resulted in lower acetate and butyrate with higher propionate and no change in total ruminal volatile fatty acids. Lasalocid-fed bulls tended to gain more weight (L = 153.6 +/- 8.5 kg, C = 138.4 +/- 7.9 kg; P less than .08), tended to have a greater average daily gain (ADG; L = .78 +/- .05 kg/d, C = .71 +/- .04 kg/d; P less than .09) and had greater feed conversion (11.5% less feed/kg gain) than did the control bulls. Lasalocid did not affect bull height (HT), weight:height ratio, length (LE) or heart girth (HG) at any time tested during puberal development. Lasalocid bulls exhibited a greater increase in HG through 175 d on treatment (L = 27.6 +/- 1.0 cm, C = 24.3 +/- 1.8 cm; P less than .05) and through first detected sperm (FS) in an ejaculate (L = 30.1 +/- 2.2 cm, C = 26.1 +/- 1.4 cm; P less than .05), but the increase in HG from the start of the trial through puberty was not different between treatments.(ABSTRACT TRUNCATED AT 250 WORDS)